CHOOSE DUPIXENT FOR YOUR APPROPRIATE PATIENTS VISIT BOOTH 1227 TO EXPLORE DUPIXENT AS A TREATMENT OPTION FIND OUT MORE ABOUT DUPIXENT © 2022 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. DUPIXENT® is a registered trademark of Sanofi Biotechnology. DUP.22.03.0005 03/2022http://www.dupixenthcp.com/asthma/congress